TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pfizer AB
Closing information (x1000 SEK)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
1,945,903
|
2,145,521
|
4,188,731 |
| Financial expenses |
2,991
|
1,794
|
3,231 |
| Earnings before taxes |
64,276
|
117,143
|
44,020 |
| EBITDA |
65,194
|
115,590
|
224,982 |
| Total assets |
1,190,152
|
1,075,587
|
1,813,396 |
| Current assets |
1,168,681
|
1,046,596
|
1,790,159 |
| Current liabilities |
760,486
|
605,971
|
1,434,189 |
| Equity capital |
429,666
|
469,616
|
379,207 |
| - share capital |
35,708
|
35,708
|
35,708 |
| Employees (average) |
158
|
155
|
145 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
36.1%
|
43.7%
|
20.9% |
| Turnover per employee |
12,316
|
13,842
|
28,888 |
| Profit as a percentage of turnover |
3.3%
|
5.5%
|
1.1% |
| Return on assets (ROA) |
5.7%
|
11.1%
|
2.6% |
| Current ratio |
153.7%
|
172.7%
|
124.8% |
| Return on equity (ROE) |
15.0%
|
24.9%
|
11.6% |
| Change turnover |
-199,618
|
-2,043,210
|
3,518,389 |
| Change turnover % |
-9%
|
-49%
|
525% |
| Chg. No. of employees |
3
|
10
|
62 |
| Chg. No. of employees % |
2%
|
7%
|
75% |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.